Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.

Nanoparticle technology presents key market opportunities in drug delivery, diagnostics, and therapeutic innovations, enhancing drug efficacy and minimizing side effects. Emerging applications in ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work -- a phenomenon called multidrug ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to cancer cells and not normal cells, potentially allowing clinicians to ...

A two-step nanoparticle system first blocks cancer cells' drug-expulsion mechanism, then releases chemotherapy combined with laser-driven heat to destroy resistant tumors.

Scientists at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have engineered polymer-based nanoparticles that form with a simple temperature shift. The team reports ...

Researchers headed by teams at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) and Memorial Sloan Kettering Cancer Center have developed what they describe as a ...

New cancer approach: CRYSTAL nanoparticles use manganese to activate the immune system’s cGAS-STING pathway, targeting tumors without causing systemic inflammation. Promising preclinical results: In ...